The company says a single node is capable of processing approximately 22,000 genomes annually, triple the amount of earlier releases.

This infographic will explore how NGS has contributed to advances in personalized cancer treatment, microbiome research and environmental sciences.

Next-generation sequencing enhances a biologics manufacturer's ability to detect and identify unknown or unexpected contaminants.

MGI Tech Co., Ltd. (MGI), a company dedicated to developing core tools and technologies that drive innovation in ...

Miami University’s Center for Bioinformatics and Functional Genomics (CBFG) has become one of the first institutions in the region to acquire the PacBio VEGA Benchtop System — a cutting-edge DNA ...

Bulk harvest release testing for adventitious viruses is an integral part of biosafety for manufacturing biopharma products. Finding a testing strategy that works for diverse biologics modalities ...

FORT DETRICK, Md. – Researchers at the U.S. Army Medical Research Institute of Infectious Diseases are testing a promising new biological threat detection method in high-fidelity training scenarios, ...

The Business Research Company’s Next Generation Tissue Biomarkers Global Market Report 2025 – Market Size, Trends, And Forecast 2025-2034 LONDON, GREATER LONDON, UNITED KINGDOM, September 12, 2025 / ...

The company opened its Solutions Centre in Bengaluru in 2023 and followed it up with the establishment of a Global Capability ...

The key market opportunities in next-generation oncology devices include enhancing precision diagnostics and targeted treatments, leveraging AI & robotics, and integrating patient-centric models.